These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17006987)

  • 1. C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma.
    Gerhardt T; Milz S; Schepke M; Feldmann G; Wolff M; Sauerbruch T; Dumoulin FL
    World J Gastroenterol; 2006 Sep; 12(34):5495-500. PubMed ID: 17006987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
    Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
    Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
    Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
    BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High C-reactive protein/albumin ratio associated with reduced survival due to advanced stage of intrahepatic cholangiocarcinoma.
    Kano H; Midorikawa Y; Song P; Nakayama H; Moriguchi M; Higaki T; Tsuji S; Takayama T
    Biosci Trends; 2020 Sep; 14(4):304-309. PubMed ID: 32507777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma.
    Weber A; Landrock S; Schneider J; Stangl M; Neu B; Born P; Classen M; Rösch T; Schmid RM; Prinz C
    World J Gastroenterol; 2007 Mar; 13(9):1422-6. PubMed ID: 17457974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical procedure and prognosis of hilar cholangiocarcinoma.
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
    Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
    J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer.
    Song DH; Cho IK; Shin DW; Lee JC; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
    Surg Today; 2021 Jun; 51(6):978-985. PubMed ID: 33387024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major hepatectomy for perihilar cholangiocarcinoma.
    Unno M; Katayose Y; Rikiyama T; Yoshida H; Yamamoto K; Morikawa T; Hayashi H; Motoi F; Egawa S
    J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):463-9. PubMed ID: 19941010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Preoperative C-reactive Protein to Albumin Ratio on the Long-Term Outcomes of Hepatic Resection for Intrahepatic Cholangiocarcinoma.
    Ito T; Shinkawa H; Takemura S; Tanaka S; Nishioka T; Miyazaki T; Ishihara A; Kubo S
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2373-2379. PubMed ID: 32856868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.
    Song SC; Choi DW; Kow AW; Choi SH; Heo JS; Kim WS; Kim MJ
    ANZ J Surg; 2013 Apr; 83(4):268-74. PubMed ID: 22943422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predict the effect of the number of positive preoperative serum tumor markers on the surgical method and prognosis of intrahepatic cholangiocarcinoma patients based on mediation analysis].
    Li ZL; Chen JL; Tang Y; Qin DL; Chen C; Qiu YH; Wu H; He Y; Mao XH; Zhai WL; Li JD; Liang X; Sun CD; Ma K; Geng ZM; Tang ZH; Quan ZW
    Zhonghua Wai Ke Za Zhi; 2024 Jul; 62(7):685-696. PubMed ID: 38808436
    [No Abstract]   [Full Text] [Related]  

  • 14. [Analysis of the relation between surgery and prognosis of hilar cholangiocarcinoma].
    Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Cheng QB; Wu MC
    Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):842-5. PubMed ID: 16083598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: a 7-year experience at a single center in Greece.
    Alexopoulou A; Soultati A; Dourakis SP; Vasilieva L; Archimandritis AJ
    World J Gastroenterol; 2008 Oct; 14(40):6213-7. PubMed ID: 18985813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma].
    Wang DD; Xu JZ; Fu Q; Fu XJ; Chen FF; Lu Z; Guo J; Ma X; Sun WL; Zhang DY
    Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):288-292. PubMed ID: 30929375
    [No Abstract]   [Full Text] [Related]  

  • 18. Preoperative C-reactive protein-to-albumin ratio predicts long-term outcomes in extrahepatic cholangiocarcinoma patients.
    Yasukawa K; Shimizu A; Motoyama H; Kubota K; Notake T; Fukushima K; Ikehara T; Hayashi H; Kobayashi A; Soejima Y
    J Surg Oncol; 2020 Nov; 122(6):1094-1105. PubMed ID: 32634266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for early bilirubinemia after major hepatectomy for perihilar cholangiocarcinoma with portal vein embolization.
    Sakamoto Y; Shimada K; Nara S; Esaki M; Kajiwara T; Arai Y; Sano T; Yamamoto J; Kosuge T
    Hepatogastroenterology; 2010; 57(97):22-8. PubMed ID: 20422866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant Precise Hemihepatectomy to Improve the Efficacy of Surgical Treatment for Hilar Cholangiocarcinoma: Analysis of 38 Cases.
    Wang L; Geng ZM; Song XG; Zhao YL; Noor H; Shi L; Liu QG
    Hepatogastroenterology; 2014 Jun; 61(132):927-32. PubMed ID: 26158143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.